FDA approves APP Pharma Nafcillin for injection, USP
APP Pharma‘s Nafcillin for injection, which is indicated for the treatment of infections caused by penicillinase-producing staphylococci, is the generic version of GlaxoSmithKline (GSK) marketed drug Nallpen and
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.